Masonic Cancer Center, University of Minnesota
March 8, 2005
Cancer Center Update is sent to Cancer Center members and staff every Tuesday at 10 a.m. To submit an item for publication, send the information to Sandi Sherman by noon the Friday before publication.
In This Issue:
Professional Education and Seminars
Grant Information & Announcements
Molecular mechanism of mammalian DNA interstrand crosslink repair
Tadayoshi Bessho, Ph.D., Assistant Professor, Eppley Institute, University of Nebraska Medical Center
Host: Natalia Tretyakova
A peek at next week’s seminar:
The bio-behavioral determinants of adolescent smoking progression
Janet Audrain-McGovern, Ph.D., Department of Psychiatry, University of Pennsylvania
Host: Katie Schmitz
For a complete schedule visit: http://www.cancer.umn.edu/page/aboutus/date.html
Thursday, March 10, 2005, 1:00-2:00 p.m., 450 CCRB
"Functional Limitations in Adult Survivors of Childhood Cancer"
Kirsten Ness, Ph.D., Assistant Professor, DPT Program, College of St. Catherine
Dr. Ness is a candidate for a faculty position in the Pediatric Clinical Research Core.
Host: Dr. Jim Gurney
AMERICAN CANCER SOCIETY INSTITUTIONAL GRANT OPPORTUNITY
American Cancer Society Institutional Research Grant applications are being accepted until May 2, 2005. This grant is for assistant professors who have no independent national funding and are engaged in cancer-related research. Cancer-related research includes genetic mechanisms of cancer, molecular mechanisms of cancer progression and metastasis, development of novel cancer therapeutic models and translational research, cancer immunology and immunotherapy. Funding is available up to $20,000. Applications may be obtained by calling 612-626-1926 or sending email to micek003@tc.umn.edu.
CANCER CENTER DIRECTOR ANNOUNCES CLINICAL TRIAL SUPPORT OPPORTUNITY
John Kersey, M.D., Director of The Masonic Cancer Center at the University of Minnesota, recently announced a Request for Applications for Clinical Cancer Trial Support. “A high priority of the Masonic Cancer Center is to foster the development and conduct of therapeutic clinical trials in cancer. Previous awards using the RFA mechanism have provided support for these studies. Again this spring we will provide up to $150,000 for clinical trials with highest priority given to local investigator-initiated therapeutic trials with likelihood of national funding.”
View the RFA for this next round. The deadline receipt of applications is APRIL 1, 2005. If you have any questions please contact Elaine Bell, R.N., 612-624-1959, email bellx060@umn.edu.
SEEKING RECOGNITION AWARD NOMINATIONS
Nominations are now open for the recognition award in Administration and Outreach. Administrative and Outreach staff, as well as other staff and faculty contributing to the Masonic Cancer Center in these areas, are eligible for this award. Nominees do not need to be Cancer Center employees.
To submit a nomination on-line, go to http://www.cancer.umn.edu/page/aboutus/recogform.html. Nomination forms may be requested from Melissa Daufelt by email at cchr@ahc.umn.edu or telephone at 626-3410. The submission deadline for nominations is March 23, 2005. Please join us for the Administration and Outreach recognition event Thursday, March 31 at 3 p.m. in room 450 CCRB.
CANCER CENTER SPRING POSTER SESSION AND SYMPOSIUM
The Sixth Annual Spring Poster Session and Symposium sponsored by the Masonic Cancer Center Core Facilities will be held from 11 a.m. to 1:30 p.m., May 19, 2005. The schedule for the event includes oral presentations from 11 a.m. to noon followed by poster session and lunch from noon to 1:30 p.m. Students, staff, post-docs and PIs are invited to participate by presenting a poster.
Online registration will open on Monday, March 21, 2005. Due to the increasing number (and size!) of posters and the limited amount of display space, we have decided to display the first 35 abstracts/posters that are submitted in the Masonic Cancer Center atrium areas. Other posters will be displayed as space permits in other areas of the Masonic Cancer Center. All abstracts will be printed in the program booklet.
For more information, call Sue Fautsch at 5-6955 or send an email to fauts001@umn.edu.
SAVE THE DATE!
The Cancer Benefit fund invites you to joint them for a wine tasting and entertainment event to benefit cancer care and research at The Masonic Cancer Center at the University of Minnesota and HealthEast Cancer Center. This year’s event, “Fiesta de Vino: A Wine Tasting Event with a South American Twist,” will be held 7 p.m. April 16, 2005 at the Radisson Plaza in Minneapolis. Enjoy wines provided by The Cellars, South American entertainment and hors d’oeuvres, a silent auction, and chance to win a trip to South America from American airlines, and more. For tickets and more information call 651-464-6049 or visit www.cancerbenefitfund.com.
CLIMB FOR THE CURE
The Children’s Cancer Research Fund will be the beneficiary of a fundraising event, Climb for the Cure, to be held April 23, 2005 from 5-10 p.m. at Vertical Endeavors in St. Paul. This will be a family-oriented, safe indoors rock climbing event for those of all ages and skill levels. Deadline for registration is April 17, 2005 and you can visit the Climb for the Cure website at www.climbcure.com or contact Cancer Center member Kathleen Conklin at 626-0445, email conkl001@umn.edu.
GRANT ANNOUNCEMENTS
Please call Kamala Upadhyaya at 626-5326 for assistance with your application.
IN UTERO EXPOSURE TO BIOACTIVE FOOD COMPONENTS AND MAMMARY CANCER RISK
Application Receipt Dates: February 1, 2005; June 1, 2005; October 1, 2005
The purpose of this initiative is to invite innovative preclinical R01 and R21 applications that promote research that will enhance the understanding of the relationship between exposures to bioactive food components and/or environmental chemicals in utero , hormonal and growth factor response, gene expression or epigenetic changes and subsequent mammary cancer risk in preclinical models. Although much evidence suggests that dietary components are linked to cancer prevention, the specific nutrients, sites of action, and role of exposure in utero remain elusive. This funding opportunity encourages applications that apply new high-throughput genomic, epigenomic, proteomic, and metabolomic technologies to determine how dietary exposures in utero influence adult breast cancer susceptibility. Because the nature and scope of the proposed research will vary from application to application, it is anticipated that the size and duration of each award will also vary. The total amount awarded and the number of awards will depend upon the numbers, qualities, durations, and costs of the applications received. For more information visit the web site.
http://grants.nih.gov/grants/guide/pa-files/PA-05-059.html
CORRELATIVE STUDIES WITH SPECIMENS FROM MULTI-SITE TRIALS
This Program Announcement (PA) replaces PA-03-064
Application Receipt Dates: February 1, 2005; June 1, 2005; October 1, 2005
The Cancer Therapy Evaluation Program (CTEP) and the Cancer Diagnosis Program (CDP), Division of Cancer Treatment and Diagnosis (DCTD) National Cancer Institution (NCI), support a program of integrated national networks of clinical investigators and institutions (NCI Clinical Trials Cooperative Groups) for the conduct of large scale, multi-institutional clinical trials. The Community Oncology and Prevention Trials Research Group, Division of Cancer Prevention (DCP), NCI, supports programs to improve clinical oncology in community settings and conducts prevention and control trials. The Early Detection Research Network (EDRN) of the Division of Cancer Prevention, NCI, has created a research platform for collaborating with the clinical trials community and appointed liaisons for the various NCI Cooperative Groups. The EDRN is available for assistance in validation studies and researchers may form collaborations through its Associate Member Program.
This funding opportunity will use the NIH investigator-initiated research project grant (R01) and the NIH exploratory/developmental grant (R21) award mechanisms. As an applicant, you will be solely responsible for planning, directing, and executing the proposed project. For the R21 mechanism, applicants may request a project period of up to 2 years with a combined budget for direct costs of up to $275,000 for the 2-year period. Because the nature and scope of the proposed research will vary from application to application, it is anticipated that the size and duration of each award will also vary. Although the financial plans of the NCI provide support for this program, awards pursuant to this funding opportunity are contingent upon the availability of funds and the receipt of a sufficient number of meritorious applications. Facilities and administrative costs requested by consortium participants are not included in the direct cost limitation. For more information visit the web site. http://grants.nih.gov/grants/guide/pa-files/PA-05-062.html
COLLABORATIONS WITH NATIONAL CENTERS FOR BIOMEDICAL COMPUTING
Letters of Intent Receipt Date(s): April 19, 2005; December 19, 2005; April 19, 2006; December 19, 2006; April 19, 2007; December 19, 2007; April 19, 2008; December 19, 2008
Application Receipt Dates(s): May 17, 2005; January 17, 2006; May 17, 2006; January 17, 2007; May 17, 2007; January 17, 2008
The purpose of this program announcement is to provide support for investigators working in collaboration with the NIH National Centers for Biomedical Computing (NCBC) using the R01 mechanism. The major goal of this program announcement is to provide the resources for a wide range of biomedical, behavioral, and computational researchers to establish new collaborations with the NIH NCBCs. Although the financial plans of the IC(s) provide support for this program, awards pursuant to this funding opportunity are contingent upon the availability of funds and the receipt of a sufficient number of meritorious applications. For more information visit the web site http://grants.nih.gov/grants/guide/pa-files/PAR-05-063.html
To view all grants available through the Masonic Cancer Center, visit http://www.cancer.umn.edu/page/aboutus/grantopp.html
Friday, March 11, 2005
Targeting the IGF system in breast cancer
Deepali Sachdev,Yee Lab
For a complete schedule visit http://www.cancer.umn.edu/page/grant7.html
For a complete schedule visit http://www.cancer.umn.edu/page/aboutus/bmtlect.html